
Home - Wockhardt
Wockhardt Global School, Aurangabad, is a not-for-profit initiative dedicated to developing a student community of lifelong learners that imbibes skills, knowledge and values required for global citizenship.
About Us - Wockhardt
Team Wockhardt Corporate Milestones Research & Development R&D at Wockhardt New Drug Discovery Pipeline / Projects News & Events
Our Business Verticals - Wockhardt
Wockhardt is a fully integrated, innovation-led company committed to provide high quality biological products at an affordable price for needy patients and healthcare systems across the globe. …
Board of Directors - Wockhardt
Today, the Wockhardt Group is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs), …
New Drug Discovery - Wockhardt
Realizing this challenge, Wockhardt discovery team embarked on identifying a novel oral respiratory antibiotic with coverage of multi-drug resistant pathogens, assuring safety profile and easy to comply …
Team Wockhardt
He provides leadership for the overall business for CP Pharmaceuticals and Wockhardt UK Ltd and grow the business in these regions through strategic business initiatives across sales, marketing, …
Contact us - Wockhardt
Wockhardt Limited E-1/1, Wockhardt Infrastructure Development Limited Five Star Industrial Estate, MIDC Shendra, Maharashtra – 431154, India Tel: +91 240 6662222 / 66662008
Chairman's Profile - Wockhardt
Today, the Wockhardt Group is India’s leading research-based, global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs), …
Corporate Milestones - Wockhardt
1967 Wockhardt founded by Dr. Habil Khorakiwala 1972 Launch of PROXYVON - the first combination formulation in pain management 1979
careers - Wockhardt
Warning: Cannot modify header information - headers already sent by (output started at /home/wockhardt/public_html/wp-content/themes/wockhardt/shortcodes/investors.php:144) in …